Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.

Headache
Mia MinenRichard B Lipton

Abstract

Scalable, accessible forms of behavioral therapy for migraine prevention are needed. We assessed the feasibility and acceptability of progressive muscle relaxation (PMR) delivered by a smartphone application (app) in the Primary Care setting. This pilot study was a non-blinded, randomized, parallel-arm controlled trial of adults with migraine and 4+ headache days/month. Eligible participants spoke English and owned a smartphone. All participants were given the RELAXaHEAD app which includes an electronic headache diary. Participants were randomized to receive 1 of the 2 versions of the app-one with PMR and the other without PMR. The primary outcomes were measures of feasibility (adherence to the intervention and diary entries during the 90-day interval) and acceptability (satisfaction levels). We conducted exploratory analyses to determine whether there was a change in Migraine Disability Assessment Scale (MIDAS) scores or a change in headache days. Of 139 participants (77 PMR, 62 control), 116 (83%) were female, mean age was 41.7 ± 12.8 years. Most patients 108/139 (78%) had moderate-severe disability. Using a 1-5 Likert scale, participants found the app easy to use (mean 4.2 ± 0.7) and stated that they would be happy to engage...Continue Reading

References

May 28, 1998·Cephalalgia : an International Journal of Headache·W M MullenersT J Steiner
Sep 10, 1999·BMJ : British Medical Journal·D G Altman, J M Bland
Jun 6, 2009·Cephalalgia : an International Journal of Headache·J E LafataR B Lipton
Oct 7, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Brian G Danaher, John R Seeley
Nov 3, 2010·Journal of Psychiatric Research·Andrew C LeonHelena C Kraemer
Jun 1, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·F Andrasik
Jul 31, 2012·Contemporary Clinical Trials·Corrine I VoilsMatthew L Maciejewski
Nov 17, 2012·Epilepsy & Behavior : E&B·Emily L PolakSheryl R Haut
May 31, 2013·Cephalalgia : an International Journal of Headache·F DekkerW J J Assendelft
Dec 26, 2013·JAMA : the Journal of the American Medical Association·Scott W PowersAndrew D Hershey
Jun 5, 2015·Current Pain and Headache Reports·Elizabeth K SengRichard B Lipton
Jul 1, 2015·Cephalalgia : an International Journal of Headache·Mia T MinenDavid Silbersweig
Aug 1, 2012·British Journal of Pain·Fayyaz Ahmed
Apr 28, 2016·Academic Medicine : Journal of the Association of American Medical Colleges·E Ray DorseyStephen H Friend
Jun 6, 2018·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Mia T MinenRichard B Lipton
Jun 8, 2018·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Mia T MinenElizabeth Seng
Nov 7, 2018·Current Treatment Options in Psychiatry·Joshua C MageeStephen Warnick
Dec 25, 2019·Cephalalgia : an International Journal of Headache·Mia T MinenElizabeth Seng

❮ Previous
Next ❯

Citations

Feb 3, 2021·Journal of General Internal Medicine·Donna LangenbahnMia T Minen
Jun 24, 2021·Headache·Jessica AilaniUNKNOWN Board of Directors of the American Headache Society

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.